vaginal candidiasis Diabetes women. Candidiasis of vulva and vagina
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Written consent for participation in the study Have at least reading and writing skills Resident of Mashhad city Married and having more than 15 years of ages Prove diabetes by examining a patient's case No history of clotrimazole susceptibility No history of allergy to the lamina family No pregnancy Non-Lactation Lack of menopause No IUD and Not using hormonal contraceptive methods Non-use of special medication within the last two weeks Failure to catch vaginal candida infection more than 4 times a year Lack of a menstrual period or any vaginal bleeding Having a score of at least 3 of the total score of symptoms and symptoms of vaginal candida infection during examination and observation In the examination of the absence of genital tract infections Positive vaginal discharge culture of a candidate Not having a medical condition other than diabetes Lack of acute and new stress in the last 8 weeks No addiction or hookah smoking Having a single partner Failure to perform curettage,Histro Salpango Graphy? surgery in the last two weeks Not getting blood and Chemotherapy in the last 4 weeks No use of antifungals to treat Vaginal infection in the last two weeks Not having sexually transmitted infections in the last month
Exclusion criteria
Exclusion criteria: Refusal to participate in research by research unit Having sensitivity to the medicine given Having acute and severe stress during treatment Use of certain medication during treatment The use of an anti fungal drug with a given drug period monthly or abnormal bleeding during the study Lack of vaginal cream over one night Antibiotic therapy during treatment Use of aromatic and sanitary materials for washing the vagina Use of herbal remedy or other anti fungal medication (topical or oral) with the medicine given
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vaginal Candidiasis in Diabetes Women. Timepoint: A week± 24 hours. Method of measurement: Culture Discharg In laboratory. | — |
Secondary
| Measure | Time frame |
|---|---|
| Itching. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: Patient's biography.;Erythema. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: Clinical examination, observation and patient history.;Irritation. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: patient history.;Painful intercourse. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: patient history.;The result of vaginal discharge culture. Timepoint: Before treatment, a week ± 24 hours after treatment. Method of measurement: vaginal discharge culture. | — |
Countries
Iran (Islamic Republic of)
Contacts
Mashhad University of Medical Sciences